Year archive

Onward Medical N.V. — 2025 filings

All 29 regulatory filings released by Onward Medical N.V. (ONWD) in 2025, sourced directly from the official regulator.

29 Filings

2025 Period

2025 filings (29)

Filing	Released	Lang
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025 Earnings Release Q3 2025	2025-11-24	English
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use Regulatory Filings	2025-11-17	English
ONWARD Medical Publishes Closing of Bookbuild Offering Capital/Financing Update	2025-10-29	English
ONWARD Medical Publishes Closing of Bookbuild Offering Share Issue/Capital Change	2025-10-28	English
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase Capital/Financing Update	2025-10-24	English
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million Capital/Financing Update	2025-10-23	English
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase Capital/Financing Update	2025-10-17	English
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States Earnings Release Q3 2025	2025-10-13	English
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States Earnings Release Q3 2025	2025-10-13	English
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy Regulatory Filings	2025-09-18	English
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy Regulatory Filings	2025-09-18	English
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe Regulatory Filings	2025-09-08	English
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025 Earnings Release H1 2025	2025-09-02	English
ONWARD Medical N.V., Halfjaarlijkse financiële verslaggeving Interim / Quarterly Report H1 2025	2025-09-02	English
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025 Earnings Release H1 2025	2025-09-02	English
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System Regulatory Filings	2025-08-19	English
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System Regulatory Filings	2025-08-18	English
ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors Board/Management Information	2025-08-06	English
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors Board/Management Information	2025-07-07	English
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders AGM Information	2025-06-12	English
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders AGM Information	2025-06-11	English
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions AGM Information	2025-05-01	English
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions AGM Information	2025-05-01	English
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions AGM Information	2025-04-30	English
ONWARD Medical Announces Release of 2024 Annual Report Report Publication Announcement	2025-04-28	English
ONWARD Medical Announces Release of 2024 Annual Report Report Publication Announcement	2025-04-28	English
ONWARD Medical N.V., Jaarlijkse financiële verslaggeving Annual Report (ESEF) FY 2024	2025-04-28	English
ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights Earnings Release FY 2024	2025-04-01	English
ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024 et partage ses faits marquants du début de l’année 2025 Earnings Release FY 2024	2025-04-01	French